Overview

Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V

Status:
Completed

Trial end date:
2021-05-31

Target enrollment:

Participant gender:

Summary

A double-blind, randomized, split-face controlled trial of 34 female patients with melasma was conducted. All subject were randomized to receive either intradermal tranexamic acid or placebo injection on the right or the left side of their face.

Phase:

N/A

Details

Lead Sponsor:

Indonesia University

Treatments:

Tranexamic Acid